Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cerus Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CERS
Nasdaq
2836
https://www.cerus.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cerus Corporation
‘Too Cheap to Ignore’: Cathie Wood Snaps Up These 2 Stocks Under $10
- Mar 10th, 2023 2:24 pm
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
- Mar 9th, 2023 4:45 pm
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results
- Feb 28th, 2023 9:00 pm
Cerus (NASDAQ:CERS) shareholders have endured a 43% loss from investing in the stock a year ago
- Feb 21st, 2023 4:00 pm
Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
- Feb 15th, 2023 1:30 pm
Cerus Corporation to Participate in Upcoming Investor Conferences
- Feb 10th, 2023 1:30 pm
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update
- Jan 9th, 2023 1:30 pm
Cerus Corporation's (NASDAQ:CERS) recent 9.2% pullback adds to one-year year losses, institutional owners may take drastic measures
- Dec 21st, 2022 10:50 am
Cerus Third Quarter 2022 Earnings: US$0.048 loss per share (vs US$0.072 loss in 3Q 2021)
- Nov 9th, 2022 10:58 am
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
- Nov 3rd, 2022 9:55 pm
Cerus Corporation Announces Third Quarter Financial Results
- Nov 3rd, 2022 8:00 pm
Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
- Nov 2nd, 2022 5:52 pm
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
- Nov 1st, 2022 12:00 pm
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
- Oct 20th, 2022 12:30 pm
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting
- Sep 26th, 2022 12:00 pm
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for Cerus (CERS)
- Sep 21st, 2022 1:35 pm
Investors in Cerus (NASDAQ:CERS) have made a decent return of 59% over the past five years
- Sep 14th, 2022 3:55 pm
Zimmer (ZBH) Surges 4.2%: Is This an Indication of Further Gains?
- Sep 13th, 2022 3:17 pm
Down 20.4% in 4 Weeks, Here's Why Cerus (CERS) Looks Ripe for a Turnaround
- Aug 29th, 2022 1:35 pm
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks
- Aug 24th, 2022 11:58 am
Scroll